Contact Us

Regarding the articles on home spirometry

Friday, February 11th, 2022

This prospective study examined the use of home spirometry in 17 adult patients with cystic fibrosis. Home monitoring of FEV1 was performed using the Vitalograph Lung Monitor device.

  • Author Curley R et al.
  • Publication Journal of Cystic Fibrosis
  • Year 2022
  • Device Type 4000 Series, Lung Monitor
Access Article

  • April 8, 2024

    Prediction model derived from large-scale proteomics for risk of chronic obstructive pulmonary disease in the general population

  • April 8, 2024

    Prevalence, characteristics and significant predictors for cardiovascular disease of patients with preserved ratio impaired spirometry: A 10-year prospective cohort study in China

  • April 8, 2024

    Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): A prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial

  • April 8, 2024

    Tomo-PIV in a patient-specific model of human nasal cavities: A methodological approach

  • April 8, 2024

    Association of systemic anticholinergic medication use and accelerated decrease in lung function in older adults

    • View All Articles

    Vitalograph is a global leader in respiratory diagnostics. We produce high quality, accurate and reliable, respiratory medical devices & services for primary, secondary healthcare and occupational health. We deliver successful clinical trials for leading pharmaceutical companies, biotechs and research organisations.

    © Vitalograph 2023 | Privacy Policy | Cookies

    Twitter Linkedin Facebook
    Quality

    Join Our Team

    Legal
    Contact Us
    Twitter Linkedin Facebook
    © Vitalograph 2011-2022 | Privacy Policy | Cookies

    Products may not be available in your region. Contact us for more details. Always read the product IFU before use.